In the year 1998, the USFDA first approved Montelukast for clinical use in the treatment of asthma. Although this drug is efficacious, the use of Montelukast is typically in addition to other treatment modalities for asthma. Furthermore, the drug can be along with inhaled corticosteroids in asthma step therapy. However, Montelukast has currently come under the FDA radar for eliciting adverse effects in the form of neuropsychiatric illnesses in patients using the drug.
Introduction: Montelukast is approved by the FDA for indications like asthma and allergies. The medicine is approved for the prevention of chronic asthma attacks in adults and children one year and older. Facts on Montelukast Apart from chronic asthma and allergies, Montelukast is also approved to prevent exercise-induced asthma in patients who are six years and older. The drug is also useful in controlling the nasal…
